Breast cancer tumour vaccines

Cancer Treatment Reviews

Volumn 23, Issue SUPPL. 1, 1997, Pages

  Miles, D ^a   Howell, A ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CARBOHYDRATE; GLYCOPROTEIN; PEPTIDE; TUMOR ANTIGEN;

ACTIVE IMMUNIZATION; ADOPTIVE IMMUNOTHERAPY; BREAST CANCER; CANCER IMMUNOTHERAPY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PASSIVE IMMUNIZATION; REVIEW; TUMOR CELL;

EID: 0030690551     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(97)90010-4     Document Type: Article

References (7)

1. S. Rosenberg Cancer vaccines based on the identification of genes encoding cancer regression antigens Immunol. Today 18 1997 175 182
2. T. Boon P.G. Coulie B. Van den Eynde Tumour antigens recognised by T cells Immunol. Today 18 1997 267 268
3. F. Hsu C.B. Casper D. Czerkinski Tumour-specific idiotype vaccines in the treatment of patients with B-cell lyphoma Blood 89 1997 3129 3135
4. G. Riethmuller E. Schneidergadicke G. Schlimok Randomized trial of monoclonal-antibody for adjuvant therapy of resected dukes-C colorectal-carcinoma Lancet 343 1994 1177 1183
5. J. Burchell R. Graham J. Taylor-Papadimitriou Active specific immunotherapy—PEM as a potential target molecule Cancer Surv. 18 1993 135 148
6. B.M. Longernecker M. Reddish D.W. Miles G.D. MacLean Synthetic tumour associated antigens as immunotherapeutic cancer vaccines Vaccine Res. 2 1993 151 162
7. Miles, D. W., Towlson, K. E., Graham, R., et al. A randomized phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pre-treatment for the active specific immunotherapy of breast cancer.